Navigation Links
Prenatal exposure to certain pesticides may negatively impact cognitive development in children
Date:4/20/2011

metabolizes organophosphates, paraoxonase 1 (PON1). They found that the negative effects of organophosphates were limited to children of mothers who carried a genotype associated with a less efficient version of this enzyme.

"Nearly a third of the mothers in this study carried the PON1 genotype that would put their children at highest risk of negative effects from organophosphate pesticide exposure," said Dr. Engel, who is currently Associate Professor of Epidemiology at the Gillings School of Global Public Health at the University of North Carolina at Chapel Hill. "These highly susceptible individuals may account for the majority of exposure-related cognitive impairment. However, it's not clear how the changing nature of general population exposure following the ban on residential use will impact our understanding of these effects. Exposure source may play an important role, and exposure through diet may now be the predominant source of exposure for the general population rather than indoor pest control."

Dr. Engel added, "Our study will be published along with two independent studies that examined prenatal organophosphate pesticide exposure in relation to childhood IQ using similar research methods. There are definite similarities in our findings that, taken as a whole, warrant careful consideration."


'/>"/>

Contact: Christie Corbett
newsmedia@mssm.edu
212-241-9200
The Mount Sinai Hospital / Mount Sinai School of Medicine
Source:Eurekalert

Page: 1 2

Related biology news :

1. Low sperm count may be associated with prenatal testosterone excess
2. Microarray analysis improves prenatal diagnosis
3. Prenatal meth exposure linked to abnormal brain development
4. How to deliver the news? New advice for doctors diagnosing prenatal Down syndrome
5. Sex-based prenatal brain differences found
6. Good parenting triumphs over prenatal stress
7. Is prenatal screening for rare diseases like spinal muscular atrophy too costly?
8. Prenatal health-care providers inconsistent in weight-gain counseling
9. Rapid prenatal test for alpha-thalassemia
10. Prenatal exposure to BPA and DES may increase breast cancer risk
11. Prenatal exposure to pesticides linked to attention problems
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... 30, 2015 Research ... addition of the "Capacitive Fingerprint Sensors Patent ... To this date, fingerprint sensing technology is the ... sensors are well developed. This patent landscape focuses ... The domain of capacitive fingerprint sensors is ...
(Date:7/2/2015)... , June 25, 2015 ... addition of the "Next Generation Biometrics Market by ... 2020" report to their offering. The ... Billion by 2020, at a CAGR of 17.9% between ... the leading application for the market. Safran SA ...
(Date:6/29/2015)... 2015 Research and Markets( ... "Latin America Biomedical Sensors Market - Growth, Trends & ... The Latin America Biomedical Sensors market is estimated at ... over the period 2014-2020 The near future ... genetic formulation of each individual. These sensors can be ...
Breaking Biology News(10 mins):Worldwide Capacitive Fingerprint Sensors Patent Landscape Market Report 2015-2020 - Main IP Holders include Seiko Epson, AuthenTec, Sony and STMicroelectronics 2Next Generation Biometrics Market 2015 - Global Forecast to 2020 with Safran, NEC, 3M Cogent, Fujitsu & Suprema Dominating the $24 Billion Market 2Next Generation Biometrics Market 2015 - Global Forecast to 2020 with Safran, NEC, 3M Cogent, Fujitsu & Suprema Dominating the $24 Billion Market 3Latin America Biomedical Sensors Market Report 2015-2020 2
... parasites and assessing severity of disease is described in ... Medicine . Researchers led by Professor Nick White from ... dangerous type of malaria, falciparum malaria. Usually the severity ... parasites in the blood under the microscope, but this ...
... Engineered bug makes key chemical precursor from grain sorghum ... production method for succinate, a key ingredient of many ... University, the technology uses a genetically modified form of ... almost pure succinate. , Finding "green" methods to make ...
... on earth range from 3.5 million to over 30 ... and described. Estimating historical biodiversity from the fossil record ... ecologists - but not paleontologists - have traditionally relied ... a long-established rule of thumb called the species-area effect: ...
Cached Biology News:Bacteria are key to 'green' plastics, drugs 2Bacteria are key to 'green' plastics, drugs 3Space matters: Estimating species diversity in the fossil record 2
(Date:7/28/2015)... , July 28, 2015 CSL Behring ... Administration has accepted for review the company,s Biologics License ... single-chain (rVIII-SingleChain) for the treatment of hemophilia A. In ... Hemophilia A is a ... VIII; nearly all affected patients are male. People with ...
(Date:7/27/2015)... Calif. , July 27, 2015  Amgen (NASDAQ: ... its second quarter financial results on Thursday, July 30, ... The announcement will be followed by a conference call ... in the call from Amgen will be Robert ... other members of Amgen,s senior management team. ...
(Date:7/27/2015)... (PRWEB) , ... July 27, 2015 , ... ... facility identification solutions, today announced a new video: 3 Ways to GHS ... Hazard Communication Standard and the Globally Harmonized System (GHS) by effectively labeling chemical ...
(Date:7/27/2015)... 27, 2015 The Brain & ... of its annual Klerman and Freedman Prizes, recognizing ... have been supported by NARSAD Young Investigator Grants. ... innovative ideas in neurobiological and psychosocial research, garner ... the early detection, treatment, prevention and cure of ...
Breaking Biology Technology:U.S. FDA Accepts for Review CSL Behring's Biologics License Application for Its Novel rVIII-SingleChain Therapy for Patients with Hemophilia A 2U.S. FDA Accepts for Review CSL Behring's Biologics License Application for Its Novel rVIII-SingleChain Therapy for Patients with Hemophilia A 3Amgen Announces Webcast of 2015 Second Quarter Financial Results 2Brady Releases “3 Roads to GHS Labels” Video 2Brain & Behavior Research Foundation Names Winners of Klerman-Freedman Prizes for Exceptional Research 2Brain & Behavior Research Foundation Names Winners of Klerman-Freedman Prizes for Exceptional Research 3Brain & Behavior Research Foundation Names Winners of Klerman-Freedman Prizes for Exceptional Research 4Brain & Behavior Research Foundation Names Winners of Klerman-Freedman Prizes for Exceptional Research 5Brain & Behavior Research Foundation Names Winners of Klerman-Freedman Prizes for Exceptional Research 6
... , KYOTO, Japan and MARCY L,ETOILE, ... bioMerieux announce today that they have entered into a ... identification in microbiology laboratories. bioMerieux will work with Shimadzu ... MALDI-TOF* mass spectrometry technology for optimized integration into the ...
... 21 /PRNewswire-FirstCall/ - YM BioSciences Inc. (NYSE YMI, TSX:YM), ... will report results from several global nimotuzumab trials in adults ... cancer at the American Society of Clinical Oncology annual meeting ... Illinois . The trials are being conducted by Oncoscience AG ...
... led by chemists and engineers from the University of Pennsylvania ... membranes and that show promise in targeted delivery of cancer ... safely to the body in the emerging field called nanomedicine. ... of the journal Science . The research ...
Cached Biology Technology:Shimadzu and bioMerieux Enter into Partnership for Mass Spectrometry Applications in Microbiology 2Shimadzu and bioMerieux Enter into Partnership for Mass Spectrometry Applications in Microbiology 3Shimadzu and bioMerieux Enter into Partnership for Mass Spectrometry Applications in Microbiology 4YM BioSciences announces presentations on global nimotuzumab trials at ASCO annual meeting 2YM BioSciences announces presentations on global nimotuzumab trials at ASCO annual meeting 3YM BioSciences announces presentations on global nimotuzumab trials at ASCO annual meeting 4YM BioSciences announces presentations on global nimotuzumab trials at ASCO annual meeting 5Penn-led collaboration mimics library of bio-membranes for use in nanomedicine, drug delivery 2Penn-led collaboration mimics library of bio-membranes for use in nanomedicine, drug delivery 3
... Recognizes Nabeta2. The epitope ... present in any other known ... expected to work on human ... highly conserved (17/19 residues). Reactivity ...
Chicken polyclonal to HAGH ( Abpromise for all tested applications). Antigen: Synthetic peptide, corresponding to N terminal amino acids 110-260 of Human HAGH. Entrez GeneID: 3029 Swiss ...
Mouse monoclonal [SPM325] to Xanthine Oxidase, prediluted ( Abpromise for all tested applications). Antigen: C terminal 358 amino acid fragment of human xanthine oxidase. Entrez Gene ID: 749...
... Disrupts biological cells for DNA ... 96 well plates (includes 96 well ... consistent lysis across the entire plate ... wells). Can be used for ...
Biology Products: